Collective Intelligence

The first interactive platform that brings together innovation players around common interest.

The First CRISPR Treatment for Patients with Sickle Cell Disease

This article discusses the first CRISPR-based treatment for sickle cell disease, caused by a genetic mutation affecting hemoglobin and deforming red blood cells. The therapy modifies hematopoietic stem cells to produce healthy red blood cells, restoring normal oxygen transport in the body.

Our comment :

The use of CRISPR directly targets the root cause of the disease, unlike traditional treatments that focus mainly on managing symptoms. This breakthrough could pave the way for genetic therapies for a variety of other hereditary diseases, revolutionizing current therapeutic approaches.
Radia Lahlou, Health tech expert
Please login in order to save this article. Close
Please login in order to save this article. Close
Please login in order to save this article. Close

The First CRISPR Treatment for Patients with Sickle Cell Disease

This article discusses the first CRISPR-based treatment for sickle cell disease, caused by a genetic mutation affecting hemoglobin and deforming red blood cells. The therapy modifies hematopoietic stem cells to produce healthy red blood cells, restoring normal oxygen transport in the body.

BLUMORPHO comment :

The use of CRISPR directly targets the root cause of the disease, unlike traditional treatments that focus mainly on managing symptoms. This breakthrough could pave the way for genetic therapies for a variety of other hereditary diseases, revolutionizing current therapeutic approaches.
Radia Lahlou, Health tech expert
Please login in order to save this article. Close
Please login in order to save this article. Close
Please login in order to save this article. Close

The First CRISPR Treatment for Patients with Sickle Cell Disease

This article discusses the first CRISPR-based treatment for sickle cell disease, caused by a genetic mutation affecting hemoglobin and deforming red blood cells. The therapy modifies hematopoietic stem cells to produce healthy red blood cells, restoring normal oxygen transport in the body.

BLUMORPHO comment :

The use of CRISPR directly targets the root cause of the disease, unlike traditional treatments that focus mainly on managing symptoms. This breakthrough could pave the way for genetic therapies for a variety of other hereditary diseases, revolutionizing current therapeutic approaches.
Radia Lahlou, Health tech expert
Please login in order to save this article. Close
Please login in order to save this article. Close
Please login in order to save this article. Close
Please login in order to save this article. Close
Please login in order to save this article. Close
Please login in order to save this article. Close

Our previous articles

Please login in order to save this article. Close
Please login in order to save this article. Close
Please login in order to save this article. Close
Please login in order to save this article. Close
Please login in order to save this article. Close